Latest Eisai News & Updates

See the latest news and media coverage for Eisai. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Eisai

Human health care company

eisai.com
Headquarters
Bunkyo-Ku, Japan
Company type
Public company
Number of employees
1,000–5,000

Last updated

Latest news about Eisai

In short: Eisai achieved major regulatory milestones for its Alzheimer's drug Leqembi and expanded its oncology portfolio through new licensing agreements.

Company announcements

  • Eisai

    Eisai opens new Global Capability Centre

    The IT hub in Visakhapatnam, India, standardizes global IT operations and drives digital transformation. An opening ceremony celebrated its launch.

  • Eisai

    Eisai receives human capital awards for third year

    Eisai earns 'Thought Leaders of Human Capital 2025' and 'Human Capital Management Excellence 2025 Gold Award' for excellent management and disclosure.

  • Eisai

    Eisai announces FDA acceptance of LEQEMBI IQLIK sBLA

    The application for subcutaneous starting dose in early Alzheimer’s is under priority review with action date May 24, 2026.

  • Eisai

    Eisai ranks 36th in Global 100 sustainability list

    It marks Eisai's tenth inclusion and highest rank among global pharmaceutical companies. Evaluation based on UN SDGs, sustainable revenue, and investment.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Eisai

Track Eisai and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.